{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:45Z","timestamp":1791215505234,"version":"4.1.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Although modern radiotherapy (RT) techniques have reduced cardiac exposure, concerns regarding RT-induced heart disease persist. Identifying which patients are most vulnerable to cardiac toxic effects is crucial for personalized survivorship care.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate whether the association between tumor laterality and ischemic heart disease (IHD) risk varies by cumulative baseline cardiovascular risk burden.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective nationwide cohort study used data on 23\u202f305 women in the Korean National Health Insurance Service database who underwent postoperative RT for breast cancer without prior IHD from January 1, 2002, to December 31, 2018. The median follow-up was 4.3 years (IQR, 2.5-6.5 years); data analysis was completed in March 2023.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Treatment laterality (left-sided vs right-sided RT) and baseline cardiovascular risk burden (defined as a count of 6 factors: age \u226555 years, obesity, smoking, hypertension, diabetes, and dyslipidemia).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The cumulative incidence of IHD was estimated using competing-risk analysis. Subdistribution hazard ratios (sHRs) were calculated using Fine-Gray models.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 23\u202f305 patients (mean [SD] age, 51.7 [9.2] years), 11\u202f723 (50.3%) received left-sided RT and 11\u202f582 (49.7%) received right-sided RT. Left-sided RT was associated with a statistically significant increase in IHD risk (sHR, 1.11; 95% CI, 1.01-1.22;\n P<\/jats:italic>\n \u2009=\u2009.04). No statistically significant difference in IHD risk between left- and right-sided RT was observed among patients with 0 to 2 cardiovascular risk factors, whereas left-sided RT was associated with significantly higher IHD risk among patients with 3 risk factors (adjusted sHR, 1.37; 95% CI, 1.10-1.71; Gray test\n P<\/jats:italic>\n \u2009=\u2009.004).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of 23\u202f305 women with breast cancer, excess cardiac risk associated with left-sided RT was concentrated among patients with 3 cardiovascular risk factors. These findings suggest that among patients with low baseline risk profiles, the difference in IHD risk between left- and right-sided treatment may be small, whereas those with high cardiovascular burden warrant prioritized access to advanced heart-sparing modalities and aggressive risk factor management.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.31356","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:00:28Z","timestamp":1788361228000},"page":"e2631356","source":"Crossref","is-referenced-by-count":1,"title":["Laterality of Breast Radiotherapy and Ischemic Heart Disease by Cardiovascular Risk Burden"],"prefix":"10.1001","volume":"9","author":[{"given":"Seung Yeun","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Kyu","family":"Noh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"6","key":"zoi260867r1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024.","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9804","key":"zoi260867r2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"zoi260867r3","doi-asserted-by":"publisher","year":"2014","journal-title":"Lancet","DOI":"10.1016\/S0140-6736(14)60488-8"},{"issue":"5","key":"zoi260867r4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005633","article-title":"Long-term cardiovascular risk after radiotherapy in women with breast cancer.","volume":"6","author":"Cheng","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"zoi260867r5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.clon.2015.06.007","article-title":"Cardiac side-effects from breast cancer radiotherapy.","volume":"27","author":"Taylor","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"zoi260867r6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013.","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"zoi260867r7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer.","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi260867r8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures.","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi260867r9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2012.10.016","article-title":"Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients.","volume":"106","author":"Nissen","year":"2013","journal-title":"Radiother Oncol"},{"issue":"4","key":"zoi260867r10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1754-9485.2012.02405.x","article-title":"Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer.","volume":"56","author":"Hayden","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"zoi260867r11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.radonc.2021.01.010","article-title":"Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: a population-based Danish Breast Cancer Group study.","volume":"157","author":"Milo","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"zoi260867r12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4048\/jbc.2020.23.e30","article-title":"Coronary event analysis in breast cancer patients who received breast-conserving surgery and post-operative radiotherapy: a Korean nationwide cohort study.","volume":"23","author":"Sung","year":"2020","journal-title":"J Breast Cancer"},{"issue":"15","key":"zoi260867r13","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials.","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"issue":"20","key":"zoi260867r14","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1.","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi260867r16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4070\/kcj.2012.42.1.10","article-title":"Validity of the diagnosis of acute myocardial infarction in Korean national medical health insurance claims data: the Korean Heart Study (1).","volume":"42","author":"Kimm","year":"2012","journal-title":"Korean Circ J"},{"issue":"9","key":"zoi260867r17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean national health information database.","volume":"50","author":"Choi","year":"2020","journal-title":"Korean Circ J"},{"issue":"1","key":"zoi260867r18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10549-014-3149-6","article-title":"Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients.","volume":"148","author":"Mast","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"zoi260867r19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fcvm.2017.00066","article-title":"Radiation-induced cardiovascular disease: a clinical perspective.","volume":"4","author":"Yusuf","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"17","key":"zoi260867r20","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/jnci\/85.17.1398","article-title":"Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen.","volume":"85","author":"Rutqvist","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi260867r21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study.","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"issue":"17","key":"zoi260867r22","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.","volume":"104","author":"Bowles","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"zoi260867r15"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853516\/chung_2026_oi_260867_1790696004.85355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:41Z","timestamp":1791212441000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.31356","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}